Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Inflammatory Bowel Diseases

Free Subscription 10.08.2026 2 Aliment Pharmacol Ther 2 Clin Gastroenterol Hepatol 5 Dig Dis Sci 1 Dis Colon Rectum 2 Gastroenterol Hepatol 1 Gastroenterology 1 Gut 1 Hum Pathol 6 Inflamm Bowel Dis 1 J Clin Gastroenterol 3 J Crohns Colitis 1 J Gastroenterol 1 Lancet Gastroenterol Hepatol 2 Minerva Gastroenterol (Torino)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. ETCHEGARAY A, Goetz N, Hanigan K, Phillips J, et al
   Editorial on: 'Lowering the C-Reactive Protein Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis'. Authors' Reply.
   Aliment Pharmacol Ther. 2026 Aug 2. doi: 10.1111/apt.70885.
   PubMed        
   
   
2. FERREIRO-IGLESIAS R, Zabana Y, Barreiro-de Acosta M
   Editorial: Risankizumab in Refractory Crohn's Disease-From Real-World Effectiveness to Strategic Positioning and Early Monitoring. Authors' Reply.
   Aliment Pharmacol Ther. 2026 Aug 2. doi: 10.1111/apt.70898.
   PubMed        
   
   

   
   Clin Gastroenterol Hepatol

3. CAMOES NEVES J, Costa D, Cristiano M, Portela F, et al
   Superior Effectiveness of Upadacitinib Over Tofacitinib and Ustekinumab in Bio-Exposed Ulcerative Colitis: The TRIDENT-UC Study.
   Clin Gastroenterol Hepatol. 2026 Aug 6:S1542-3565(26)00561.
   PubMed         Abstract available
   
   
4. SUN J, Li L, Chang Z, Butwicka A, et al
   Psychiatric disorders before and after inflammatory bowel disease diagnosis: a nationwide cohort study in Sweden 2007-2023.
   Clin Gastroenterol Hepatol. 2026 Jul 15:S1542-3565(26)00485.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

5. TSE CS
   Letter to the Editor Regarding Barkan et al.'s Article, "Randomized Trial of Intensive Nurse?Led Follow?up Versus Standard Care in Inflammatory Bowel Disease".
   Dig Dis Sci. 2026 Aug 3. doi: 10.1007/s10620-026-10160.
   PubMed        
   
   
6. CHEN H, Zhang H
   To Clarify the Independent Role of Digital Learning and Nurse Support in the Self-Management of Inflammatory Bowel Disease.
   Dig Dis Sci. 2026 Aug 2. doi: 10.1007/s10620-026-10158.
   PubMed        
   
   
7. SINGH P, Mahajan M, Garg R, Narang H, et al
   Translating IBD Genomics into Clinical Practice.
   Dig Dis Sci. 2026;71:3146-3158.
   PubMed         Abstract available
   
   
8. ALSAKARNEH S, Aburumman R, Khraisat F, Odeh T, et al
   Major Adverse Cardiovascular Events and VTE in Patients with IBD Taking Anti-TNF versus JAK Inhibitors: A Multicenter Cohort Analysis.
   Dig Dis Sci. 2026;71:2896-2904.
   PubMed         Abstract available
   
   
9. GE Y, Li M, Guo D, Li T, et al
   Adipokine CTRP12 Alleviates Experimental Colitis by Participating in Modulating Mesenteric M2 Macrophage Polarization in IL-10 KO Mice.
   Dig Dis Sci. 2026;71:2812-2824.
   PubMed         Abstract available
   
   

   
   Dis Colon Rectum

10. TAYLOR KK, Kin CJ, Kirilcuk NN, Morris AM, et al
    Trends in the Utilization of Two-Stage Versus Three-Stage Ileal Pouch Anal Anastomosis Among Privately Insured Patients With Ulcerative Colitis in the USA, 2007 to 2023.
    Dis Colon Rectum. 2026 Aug 5. doi: 10.1097/DCR.0000000000004415.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

11. MATEOS B, Dotti I, Conde-Aranda J, de Prado A, et al
    Inflammatory Bowel Disease in Spain: Scientific Output, Collaboration and Research Characteristics.
    Gastroenterol Hepatol. 2026 Aug 8:502838. doi: 10.1016/j.gastrohep.2026.502838.
    PubMed         Abstract available
    
    
12. DAMASCENO J, Carvalho T, Arroja B, Soares J, et al
    Improving quality in IBD - Evaluation of corticosteroid excess prescription trends and its predictive role in disease-related outcomes.
    Gastroenterol Hepatol. 2026;49:502716.
    PubMed         Abstract available
    
    

    
    Gastroenterology

13. FRASCATANI R, Monteleone G
    Acquired Loss of IL-10 Function in Inflammatory Bowel Disease.
    Gastroenterology. 2026 Aug 4:S0016-5085(26)07129.
    PubMed        
    
    

    
    Gut

14. AWONIYI M, El Hag M, Hernandez J, Yang Q, et al
    Dysbiotic microbiota trigger colitis-associated colorectal cancer and imprint a distinctive bile acid profile in a PSC-IBD model.
    Gut. 2026 Mar 23:gutjnl-2025-336675. doi: 10.1136/gutjnl-2025-336675.
    PubMed         Abstract available
    
    

    
    Hum Pathol

15. LAW T, Wang D, Lauwers GY, Choi WT, et al
    Nonconventional colorectal dysplasia is less prevalent and has a more limited morphologic spectrum in patients without inflammatory bowel disease.
    Hum Pathol. 2026 Aug 4:106231. doi: 10.1016/j.humpath.2026.106231.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

16. LI H, Lu Z, Denson N, Pan W, et al
    Multi-modal ensemble learning prediction of anti-TNF treatment response in pediatric patients with Crohn's disease using clinical, radiomic, and deep learning MR enterography features.
    Inflamm Bowel Dis. 2026 Aug 7:izag156. doi: 10.1093.
    PubMed         Abstract available
    
    
17. MIYATANI Y, Hudson A, Kellar A, St-Pierre J, et al
    Clinical appraisal of handheld intestinal ultrasound in inflammatory bowel disease: Where are we now?
    Inflamm Bowel Dis. 2026 Aug 7:izag147. doi: 10.1093.
    PubMed         Abstract available
    
    
18. FUCHS T, Stadlbauer V
    Sarcopenia as a prognostic marker in inflammatory bowel disease: Implications for endoscopic outcomes and loss of response to biologic therapy-A systematic review with narrative synthesis.
    Inflamm Bowel Dis. 2026 Aug 7:izag162. doi: 10.1093.
    PubMed         Abstract available
    
    
19. SHAH RS, Bachour SP, Xiao H, Yang Q, et al
    Reutilization of biologics for postoperative Crohn's disease recurrence prevention is effective.
    Inflamm Bowel Dis. 2026 Aug 6:izag157. doi: 10.1093.
    PubMed         Abstract available
    
    
20. DESAI A, Dapke K, Habib H, Hashash JG, et al
    Appendectomy before or after ulcerative colitis diagnosis is not associated with improved long-term outcomes: a multicenter real-world study.
    Inflamm Bowel Dis. 2026 Aug 6:izag159. doi: 10.1093.
    PubMed         Abstract available
    
    
21. YARATHA L, Deogaonkar A, Vemulakonda P, Ezhil SR, et al
    Readability and quality of online inflammatory bowel disease pregnancy resources.
    Inflamm Bowel Dis. 2026 Aug 4:izag153. doi: 10.1093.
    PubMed        
    
    

    
    J Clin Gastroenterol

22. TRUMBLE L, Klibansky D
    The Appendix: More Than a Colonoscopy Landmark. The Role of the Appendix in GI Health and Disease.
    J Clin Gastroenterol. 2026;60:676-684.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

23. HAYEK MA, Estevinho MM, Kayal M, Hayek OA, et al
    Comparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression.
    J Crohns Colitis. 2026;20:jjag111.
    PubMed         Abstract available
    
    
24. BERSET IP, Lerang F, Moum B, Jahnsen J, et al
    Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial.
    J Crohns Colitis. 2026;20:jjag110.
    PubMed         Abstract available
    
    
25. UKASHI O, Albshesh A, Ungar B, Varon D, et al
    Multimodal monitoring of pan-enteric mucosal healing and biologic persistence in Crohn's disease-the MILESTONE-CD prospective cohort.
    J Crohns Colitis. 2026;20:jjag118.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

26. JOMAA A, Bshara R, Alani M, Ismail B, et al
    S1P receptor modulators for moderate-to-severe ulcerative colitis: a systematic review, meta-analysis, and trial sequential analysis.
    J Gastroenterol. 2026 Aug 2. doi: 10.1007/s00535-026-02485.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

27. SIEGMUND B
    A decade in inflammatory bowel disease: progress, plateaus, and perspectives.
    Lancet Gastroenterol Hepatol. 2026;11:735-736.
    PubMed        
    
    

    
    Minerva Gastroenterol (Torino)

28. PUCA P, Del Chierico F, Graziani C, Masi L, et al
    The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patients.
    Minerva Gastroenterol (Torino). 2026 Aug 3. doi: 10.23736/S2724-5985.26.04023.
    PubMed         Abstract available
    
    
29. D'ONOFRIO AM, Bertin L, Ferrajoli GF, Pirro P, et al
    Beyond mood: the neurobiological rationale for using SSRIs and SNRIs in the care of inflammatory bowel disease and disorders of gut-brain interaction.
    Minerva Gastroenterol (Torino). 2026 Aug 3. doi: 10.23736/S2724-5985.26.04180.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum